Last checked at 8 Jun 2020 16:06
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Evgen Pharma Share News (EVG)
EVG Share
Price
EVG Share
News
EVG Share
Chat
EVG Share
Trades
EVG
Live RNS
EVG Share
Charts
EVG Level 2
Console
EVG Live
Share Price
EVG Broker
Ratings
EVG Directors
Deals
EVG Financial
Diary
EVG
Fundamentals
EVG Short
Positions
EVG
Media
Evgen Pharma Information
Share Price Information for Evgen Pharma (EVG)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
0.80
Bid:
0.75
Ask:
0.85
Change:
0.00 (0.00%)
Spread:
0.10 (13.333%)
Open:
0.80
High:
0.80
Low:
0.80
Prev. Close:
0.80
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.13 Feb 2020 16:17
Evgen Pharma, Rochester University To Advance SFX-01 For Trial
Evgen Pharma, Rochester University To Advance SFX-01 For Trial
Read more6 Feb 2020 13:45
Evgen Pharma Hails "Positive" Data From Breast Cancer Drug Research
Evgen Pharma Hails "Positive" Data From Breast Cancer Drug Research
Read more17 Dec 2019 15:35
Evgen Pharma narrows loss, foresees 'clinical success'
(Sharecast News) - Evgen Pharma on Tuesday reported a narrowed interim loss and said it was confident of clinical success as it continues to develop its SFX-01 treatment.
Read more17 Dec 2019 11:28
Evgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss
Evgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss
Read more10 Dec 2019 15:59
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more5 Dec 2019 16:36
Evgen Pharma to advance SFX-01 trial with University of Dundee
(Sharecast News) - Clinical-stage drug development company Evgen Pharma has entered into a memorandum of understanding with the University of Dundee, it announced on Thursday, to advance SFX-01 towards a clinical trial in non-alcoholic steatohepatitis (NASH) and liver fibrosis.
Read more5 Dec 2019 15:19
Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials
Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials
Read more11 Nov 2019 12:23
UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development
UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development
Read more11 Nov 2019 10:22
UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance
UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance
Read more11 Nov 2019 09:11
Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results
Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results
Read more23 Sep 2019 13:09
Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results
Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results
Read more23 Sep 2019 10:03
Evgen Pharma upbeat on latest news from SFX-01 studies
(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Monday that five patients who participated in the 'STEM' trial received 'SFX-01' treatment for more than one year, with two of those patients continuing to be treated with SFX-01.
Read more28 Aug 2019 14:30
Evgen Pharma completes patient study visits in 'SAS' phase 2 trial
(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Wednesday that the last study visit for the last patient entered in the double-blind, placebo-controlled 'SAS' phase 2 clinical trial has taken place.
Read more28 Aug 2019 12:06
Evgen Pharma Receives Last Patient For Stroke Treatment Drug Trial
(Alliance News) - Evgen Pharma PLC said Wednesday it has entered its last patient in the double-blind, placebo-controlled SAS Phase II clinical trial that is testing its SFX-01 product, aimed at a
Read more